Literature DB >> 9784087

Antidepressant-like effect of Hypericum perforatum (St John's wort) on the sleep polysomnogram.

A L Sharpley1, C L McGavin, R Whale, P J Cowen.   

Abstract

We studied the effect of two doses (0.9 mg and 1.8 mg) of Hypericum perforatum (St John's wort) on the sleep polysomnogram of healthy subjects using a placebo-controlled, cross-over design. Both doses of hypericum significantly increased the latency to rapid eye movement (REM) sleep without producing any other effect on sleep architecture. Our data are consistent with the proposed clinical antidepressant efficacy of hypericum, and raise the possibility that its pharmacological mechanism of action may be similar to that of conventional antidepressant medication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784087     DOI: 10.1007/s002130050718

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  5 in total

Review 1.  [Sleep disorders in depression. Suggestions for a therapeutic approach].

Authors:  C Zimmermann; H Pfeiffer
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

2.  Morus nigra and its major phenolic, syringic acid, have antidepressant-like and neuroprotective effects in mice.

Authors:  Ana Paula Dalmagro; Anderson Camargo; Ana Lúcia Bertarello Zeni
Journal:  Metab Brain Dis       Date:  2017-08-18       Impact factor: 3.584

3.  Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep.

Authors:  Oliviero Bruni; Luigi Ferini-Strambi; Elena Giacomoni; Paolo Pellegrino
Journal:  Nutrients       Date:  2021-02-06       Impact factor: 5.717

Review 4.  Hypericum perforatum: Traditional uses, clinical trials, and drug interactions.

Authors:  Seyedeh Zahra Nobakht; Maryam Akaberi; Amir Hooshang Mohammadpour; Ali Tafazoli Moghadam; Seyed Ahmad Emami
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532

5.  Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double blind randomized placebo controlled trial.

Authors:  Lauren K Lazowski; Ben Townsend; Emily R Hawken; Ruzica Jokic; Regina du Toit; Roumen Milev
Journal:  BMC Psychiatry       Date:  2014-07-17       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.